Patents

Methods and compositions for the treatment of gliomas

Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto

  • US10568889 (Issued on February 25, 2020), licensed to Pyrefin Inc.
  • US10052332 (Issued on August 21, 2018), licensed to Pyrefin Inc.
  • US10040783 (Issued on August 7, 2018), licensed to Pyrefin Inc.
  • US9518044 (Issued on December 13, 2016), licensed to Pyrefin Inc.

Pending